News
The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...
Results showed that 62.9% of patients on Ozempic saw a reduction in liver inflammation, compared to 34.3% on placebo.
Understanding the complex hormonal science behind weight loss injections - and why they must remain strictly ...
Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine.
Mar. 24, 2025 — A comprehensive study shows that people with fatty liver disease have almost twice the mortality rate of the general population. They have an increased risk of dying from both ...
A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...
The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...
Metformin reduced knee arthritis pain during a six-month treatment period, potentially delaying the need for knee replacement ...
Semaglutide - the active ingredient in medications like Ozempic and WeGovy - is only FDA approved for Type-2 diabetes, but ...
Viking's leading drug candidate could be a blockbuster in the weight loss market, which experts believe could grow to $150 billion over the coming years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results